Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121

被引:4
|
作者
Lee, Wen Shi [1 ]
Reynaldi, Arnold [2 ]
Amarasena, Thakshila [1 ]
Davenport, Miles P. [2 ]
Parsons, Matthew S. [1 ,3 ,4 ]
Kent, Stephen J. [1 ,5 ]
机构
[1] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[2] Univ New South Wales, Kirby Inst, Kensington, NSW, Australia
[3] Emory Univ, Sch Med, Dept Pathol, Lab Med, Atlanta, GA 30322 USA
[4] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA
[5] Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr & Dept Infect Dis, Melbourne, Vic, Australia
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
HIV; broadly neutralizing antibodies (bNAb); PGT121; anti-drug antibodies (ADA); pigtailed macaque; MONOCLONAL-ANTIBODIES; NONHUMAN-PRIMATES; PROTECTION; VIREMIA; DELIVERY;
D O I
10.3389/fimmu.2021.749891
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic administration of the anti-HIV bNAb PGT121 (either WT or LALA version) controlled viraemia in pigtailed macaques with ongoing SHIV infection. We now report on 23 macaques that had multiple treatments with PGT121. We found that an increasing number of intravenous doses of PGT121 or human IgG1 isotype control antibodies (2-4 doses) results in anti-PGT121 ADA induction and low plasma concentrations of PGT121. ADA was associated with poor or absent suppression of SHIV viremia. Notably, ADA within macaque plasma recognised another human bNAb 10E8 but did not bind to the variable domains of PGT121, suggesting that ADA were primarily directed against the constant regions of the human antibodies. These findings have implications for the development of preclinical studies examining multiple infusions of human bNAbs.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
    Julien, Jean-Philippe
    Sok, Devin
    Khayat, Reza
    Lee, Jeong Hyun
    Doores, Katie J.
    Walker, Laura M.
    Ramos, Alejandra
    Diwanji, Devan C.
    Pejchal, Robert
    Cupo, Albert
    Katpally, Umesh
    Depetris, Rafael S.
    Stanfield, Robyn L.
    McBride, Ryan
    Marozsan, Andre J.
    Paulson, James C.
    Sanders, Rogier W.
    Moore, John P.
    Burton, Dennis R.
    Poignard, Pascal
    Ward, Andrew B.
    Wilson, Ian A.
    PLOS PATHOGENS, 2013, 9 (05)
  • [32] The optimal management of anti-drug antibodies to infliximab and identification of anti-drug antibody values for clinical outcomes in patients with inflammatory bowel disease
    Mc Gettigan, Neasa
    Afridi, Aman Shah
    Harkin, Grace
    Lardner, Caroline
    Patchett, Stephen
    Cheriyan, Danny
    Harewood, Gavin
    Boland, Karen
    O'Toole, Aoibhlinn
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (06) : 1231 - 1241
  • [33] Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
    Johansson, Maria U.
    Weinert, Christopher
    Reichardt, Dietrich Alexander
    Mahler, Dana
    Diem, Dania
    Hess, Christian
    Feusi, Diana
    Carnal, Simon
    Tietz, Julia
    Giezendanner, Noreen
    Spiga, Fabio Mario
    Urech, David
    Warmuth, Stefan
    MABS, 2023, 15 (01)
  • [34] Using serum metabolomics to predict development of neutralising anti-drug antibodies in multiple sclerosis patients treated with IFNβ
    Waddington, K.
    Coelewij, L.
    Adriani, M.
    Donnes, P.
    Nytrova, P.
    Havrdova, E. Kubala
    Farrell, R.
    Pineda-Torra, I.
    Jury, E.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 852 - 853
  • [35] Functional cellular based assay reveals neutralising anti-drug antibodies in IBD patients treated with maintenance adalimumab
    Casteele, N. Vande
    Peeters, M.
    Ferrante, M.
    Compernolle, G.
    Van Assche, G.
    Vermeire, S.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S268 - S269
  • [36] Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis
    Weifeng Xu
    Brian Maas
    Brad Roadcap
    Aparna Swarup
    Thomas Steinmetz
    Linlin Luo
    Marina Ichetovkin
    Sandra Wood
    Faye Vazvaei-Smith
    Andrew Wen-Tseng Lee
    Kalpit Vora
    Roy Helmy
    The AAPS Journal, 24
  • [37] Neutralization Activity of Anti-drug Antibodies Against a Biotherapeutic Can Be Predicted from a Comprehensive Pharmacokinetics, Pharmacodynamics, and Anti-drug Antibody Data Analysis
    Xu, Weifeng
    Maas, Brian
    Roadcap, Brad
    Swarup, Aparna
    Steinmetz, Thomas
    Luo, Linlin
    Ichetovkin, Marina
    Wood, Sandra
    Vazvaei-Smith, Faye
    Lee, Andrew Wen-Tseng
    Vora, Kalpit
    Helmy, Roy
    AAPS JOURNAL, 2022, 24 (06):
  • [38] Positivity thresholds of total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
    Nice, R.
    Chanchlani, N.
    Green, H.
    Bewshea, C.
    Kennedy, N.
    Ahmad, T.
    Goodhand, J.
    McDonald, T.
    Perry, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S018 - S019
  • [39] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
    Cheifetz, Adam S.
    Abreu, Maria T.
    Flier, Sarah N.
    Papamichail, Konstantinos
    Rieder, Florian
    Silverberg, Mark S.
    Khanna, Reena
    Okada, Lauren
    Yang, Lei
    Jain, Anjali
    Vande Casteele, Niels
    GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
  • [40] Anti-drug Antibodies in Normal Subjects Receiving a Single Dose of Intravenous Infliximab and Their Pharmacokinetic Effects
    Ehrenpreis, Eli
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S389 - S390